Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice

Nature

Volumn 449, Issue 7160, 2007, Pages 361-365

  Travis, Mark A ^a,e   Reizis, Boris ^b   Melton, Andrew C ^a   Masteller, Emma ^c   Tang, Qizhi ^c   Proctor, John M ^d   Wang, Yanli ^a   Bernstein, Xin ^a   Huang, Xiaozhu ^a   Reichardt, Louis F ^d   Bluestone, Jeffrey A ^c   Sheppard, Dean ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF SAN FRANCISCO   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; INTEGRIN ALPHA5BETA8; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

GROWTH REGULATOR; IMMUNE SYSTEM; IMMUNITY; PHENOTYPE; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL SECRETION; COLITIS; COLON; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; DISEASE SEVERITY; ENTERITIS; FEMALE; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; IMMUNOPATHOLOGY; IN VITRO STUDY; LEUKOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

MUS;

EID: 34548208943     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06110     Document Type: Article

References (30)

1. Shull, M. M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699 (1992).
2. Marie, J. C., Liggitt, D. & Rudensky, A. Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity 25, 441-454 (2006).
3. Li, M. O., Sanjabi, S. & Flavell, R. A. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25, 455-471 (2006).
4. Annes, J. P., Munger, J. S. & Rifkin, D. B. Making sense of latent TGFβ activation. J. Cell Sci. 116, 217-224 (2003).
5. Huang, X. Z. et al. Inactivation of the integrin β6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J. Cell Biol. 133, 921-928 (1996).
6. Munger, J. S. et al. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319-328 (1999).
7. Mu, D. et al. The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1. J. Cell Biol. 157, 493-507 (2002).
8. Yang, Z. et al. Absence of integrin-mediated TGFβ1 activation in vivo recapitulates the phenotype of TGFβ1-null mice. J. Cell Biol. 176, 787-793 (2007).
9. Zhu, J. et al. β8 integrins are required for vascular morphogenesis in mouse embryos. Development 129, 2891-2903 (2002).
10. Proctor, J. M., Zang, K., Wang, D., Wang, R. & Reichardt, L. F. Vascular development of the brain requires β8 integrin expression in the neuroepithelium. J. Neurosci. 25, 9940-9948 (2005).
11. de Boer, J. et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33, 314-325 (2003).
12. Gorelik, L. & Flavell, R. A. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171-181 (2000).
13. Kim, B. G. et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441, 1015-1019 (2006).
14. Bohr, U. R. et al. Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility. J. Clin. Microbiol. 44, 738-742 (2006).
15. Taylor, N. S., Xu, S., Nambiar, P., Dewhirst, F. E. & Fox, J. G. Enterohepatic Helicobacter species are prevalent in mice obtained from commercial and academic institutions in Asia, Europe, and North America. J. Clin. Microbiol. 45, 2166-2172 (2007).
16. Whary, M. T. & Fox, J. G. Detection, eradication, and research implications of Helicobacter infections in laboratory rodents. Lab Anim. (NY) 35, 25-36 (2006).
17. Strober, W., Fuss, I. & Mannon, P. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 117, 514-521 (2007).
18. Lee, P. P. et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15, 763-774 (2001).
19. - dendritic cells in the spleen. J. Exp. Med. 204, 1653-1664 (2007).
20. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8-27 (2006).
21. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
22. + regulatory T cell activity in both humans and mice. J. Immunol. 172, 834-842 (2004).
23. + regulatory T cells. J. Exp. Med. 201, 737-746 (2005).
24. + regulatory T cells. J. Exp. Med. 201, 1061-1067 (2005).
25. Fontenot, J. D. et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22, 329-341 (2005).
26. Bluestone, J. A. & Abbas, A. K. Natural versus adaptive regulatory T cells. Nature Rev. Immunol. 3, 253-257 (2003).
27. + regulatory T cells control autoimmunity? Curr. Opin. Immunol. 17, 638-642 (2005).
28. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. & Flavell, R. A. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24, 99-146 (2006).
29. Lefrancois, L. & Lycke, N. Isolation of mouse small intestine intraepithelial lymphocytes, Peyer's patch, and lamina propria cells. Curr. Protocols Immunol. Unit 3.19 doi:10.1002/0471142735.im0319s17 (2001).
30. Abe, M. et al. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216, 276-284 (1994).